These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1771186)

  • 1. Time evolution of bone/soft-tissue ratio with dynamic SPET.
    De Freitas JM
    Phys Med Biol; 1991 Dec; 36(12):1687-91. PubMed ID: 1771186
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonosseous abnormalities on bone scans.
    Loutfi I; Collier BD; Mohammed AM
    J Nucl Med Technol; 2003 Sep; 31(3):149-53; quiz 154-6. PubMed ID: 12968045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamut: soft tissue uptake of bone radiopharmaceuticals.
    Tuncel M; Erbas B; Mahmoudian B
    Semin Nucl Med; 2003 Oct; 33(4):334-7. PubMed ID: 14625845
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of tc-99m MDP, HMDP, and DPD with respect to bone-to-soft tissue ratios.
    Buell U; Kirsch CM; Kleinhans E; Jäger B
    J Nucl Med; 1983 Dec; 24(12):1201-2. PubMed ID: 6227711
    [No Abstract]   [Full Text] [Related]  

  • 5. The value of local 99mTc(Sn)-MDP bone to soft tissue uptake ratio in osteoporosis, before and during fluoride therapy.
    Raymakers JA; Savelkoul TJ; Hoekstra A; Visser WJ; van Rijk PP; Duursma SA
    Eur J Nucl Med; 1990; 16(3):157-60. PubMed ID: 2364958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental diagnostic value of SPET/CT in precise localization of extraskeletal uptake of bone-seeking agents in multiple myeloma.
    Gholamrezanezhad A; Sabet A; Ezziddin S; Biersack HJ; Ahmadzadehfar H
    Hell J Nucl Med; 2010; 13(3):285-6. PubMed ID: 21193889
    [No Abstract]   [Full Text] [Related]  

  • 7. Spleen Uptake on a Bone Scan.
    Kaur H; Muhleman M; Balon HR
    J Nucl Med Technol; 2017 Sep; 45(3):245-246. PubMed ID: 28611233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone uptake studies in rabbits before and after high-dose treatment with 153Sm-EDTMP or 186Re-HEDP.
    Brenner W; Kampen WU; Brümmer C; von Forstner C; Zuhayra M; Czech N; Muhle C; Henze E
    J Nucl Med; 2003 Feb; 44(2):247-51. PubMed ID: 12571217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of technetium-99m MDP in primary amyloidosis with a review of the mechanisms of soft tissue localization of bone seeking radiopharmaceuticals.
    Worsley DF; Lentle BC
    J Nucl Med; 1993 Sep; 34(9):1612-5. PubMed ID: 8355083
    [No Abstract]   [Full Text] [Related]  

  • 10. A report on the incidence of intestinal 99mTc-methylene diphosphonate uptake of bone scans and a review of the literature.
    Ergün EL; Kiratli PO; Günay EC; Erbaş B
    Nucl Med Commun; 2006 Nov; 27(11):877-85. PubMed ID: 17021428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transiently increased MDP activity in the soft tissue of lower extremity caused by iliofemoral venous thrombosis.
    Yu JQ; Zhuang H; Posteraro A; Reddy S; Alavi A
    Clin Nucl Med; 2005 Nov; 30(11):742-3. PubMed ID: 16237301
    [No Abstract]   [Full Text] [Related]  

  • 12. Diffuse facial uptake on bone scintigraphy.
    Brans B; Verzijlbergen JF
    Semin Nucl Med; 2000 Jan; 30(1):70-3. PubMed ID: 10656247
    [No Abstract]   [Full Text] [Related]  

  • 13. Subcutaneous injection of the HIV-1 fusion inhibitor enfuvirtide (FUZEON) may result in soft-tissue accumulation of Tc-99m MDP.
    Pack LE; Zuckier LS
    Clin Nucl Med; 2012 Jan; 37(1):100-1. PubMed ID: 22157043
    [No Abstract]   [Full Text] [Related]  

  • 14. SPECT-CT for characterization of extraosseous uptake of 99mTc-methylene diphosphonate on bone scintigraphy.
    Soundararajan R; Naswa N; Sharma P; Karunanithi S; Nazar AH; Das KJ; Bal C; Malhotra A; Kumar R
    Diagn Interv Radiol; 2013; 19(5):405-10. PubMed ID: 23748034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A trial of the quantitative bone scintigraphy in bone metabolic disease].
    Taniguchi Y; Torizumi K; Katu N; Kiji S; Yamada R; Shimizu E; Moriyama M; Okamoto Y; Ota K; Maeda J
    Radioisotopes; 1986 Jan; 35(1):28-31. PubMed ID: 3704201
    [No Abstract]   [Full Text] [Related]  

  • 16.
    Braat AJAT; Heerma van Voss MR; Bijlsma RM
    Lancet Oncol; 2021 May; 22(5):e216. PubMed ID: 33932384
    [No Abstract]   [Full Text] [Related]  

  • 17. 99m-Tc HMDP bone scintigraphic findings of gouty arthropathy of both hands: extending soft tissue uptake adjacent to the joints.
    Shih WJ; Purcell M; Domstad PA; DeLand FH
    Radiat Med; 1988; 6(1):9-11. PubMed ID: 3413289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung, gastric, and soft tissue uptake of Tc-99m MDP and Ga-67 citrate associated with hypercalcemia.
    Castaigne C; Martin P; Blocklet D
    Clin Nucl Med; 2003 Jun; 28(6):467-71. PubMed ID: 12911094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Extraosseous tumor uptake of 99m technetium methylendiphosphonate in children with neuroblastoma (author's transl)].
    Mancini AF; Turba E; Vallicelli R; Vitelli A; Fini A; Rosito P
    Pediatr Med Chir; 1981; 3(6):535-9. PubMed ID: 6211661
    [No Abstract]   [Full Text] [Related]  

  • 20. [Quantification in bone scintigraphy with Tc-99m-phosphonates: determinants and data points].
    Büll U; Reinartz P
    Nuklearmedizin; 2000 Aug; 39(5):N69-71. PubMed ID: 10984892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.